Phase 4 N=74 Continuous Glucose Sensor Profiles in Non-Diabetic Subjects
Healthy Subjects Without Type 1 Diabetes
Primary: Overall Mean Sensor Glucose by Age Group — 98; 103; 97; 96 mg/dL — p=0.009
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=5 The Impact of Environmental Controls on Mental Health
Neurologic Disorders
Primary: Percentage of Participants Achieving MCID in PROMIS Global10 Score. — 5 Participants
N/A N=20 Early Feasibility Study 2 of Outpatient Control-to-Range - Testing System Efficacy
Diabetes Mellitus, Type 1
Primary: Safety, Low Blood Glucose Index (LBGI) — 0.64; 1.12 index score — p=0.003
N/A N=20 Closed Loop Control in Adolescents Using Heart Rate as Exercise Indicator
Type 1 Diabetes Mellitus
Primary: Low Blood Glucose Index (LBGI) — 1.4; 1.9 index score
Phase 2 N=155 Environmental Control as Add-on Therapy in Childhood Asthma
Asthma
Primary: The Medication Treatment Step Assigned — 4.03; 4.05 score on a scale
N/A N=16 Active and Passive Music Therapy Interventions
Autonomic Nervous System Imbalance · Hypothalamic Pituitary Adrenal Axis Suppression
Primary: Change From Baseline to Post Intervention High Frequency (HF) and Low Frequency Divided by High Frequency (LF/HF) Power Amplitude — 0.1796; 0.1507; -0.3872; 0.3731…
N/A N=333 The Smart Hypertension Control Study
Hypertension
Primary: Blood Pressure at 6 Months — 135.0; 132.3; 85.6; 85.1 mmHG
N/A N=10 Quality Control of CE-Certified Phonak Hearing Aids - 2020_43
Hearing Loss
Primary: Subjective Listening Effort Scaling — -2.276; -0.917 SNR (dB)
N/A N=75 Self-Control and Adult Cigarette Smokers
Smoking
Primary: Self- Control as Measured by the Change in the Length of Time Participants Can Hold a Hand-grip at Baseline and Follow-up (One Week After Baseline) — -9.36; 2.76; -4.32…
N/A N=987 An Observational Cohort Study to Evaluate the Safety and Efficacy of Micardis Tablets Taken Once Daily at 40 mg/Day and 80 mg/Day in Hypertensive Patients Under Real Life Conditions in Usual Clinical Practice
Hypertension
Primary: Number of Patients Achieving Blood Pressure (BP) Control, Sitting Diastolic BP Over Systolic BP 90 Over 140 mm Hg and/or Reduction From Baseline in Sitting Systolic BP…
N/A N=100 Self-Control in Bulimia Nervosa
Bulimia Nervosa
Primary: Brain Activation Associated With P(Stop) — 0.02; 0.11; 0.04; 0.05 BOLD Signal
N/A N=20 Outpatient Control-to-Range: System and Monitoring Testing
Type 1 Diabetes Mellitus
Primary: Percent Time of Active CTR — 98 percentage of time of active CTR
N/A N=162 KBTH-GIRHL Healthy Birth Weight Study: A Cross-Section
Infant, Small for Gestational Age · Infant, Low Birth Weight · Pregnancy
Primary: Birth Weight of Baby — 3033 grams
N/A N=45 Diabetes Prevention and Control in the Workplace: A Pilot Study
Type 2 Diabetes Mellitus
Primary: Body Weight — -2.3; 0.73 kg — p=<0.01
N/A N=38 Feasibility Study of a Modular Control to Range System in Type 1 Diabetes Mellitus
Type 1 Diabetes Mellitus
Primary: Hypoglycemic Events — 1.08; 0.4; 1.4; 1.6 events/admission per patient
N/A N=34 Inhibitory Control Adult Weight Management
Overweight and Obesity
Primary: BMI at Three Months — 34.53; 34.43 kg/m^2
N/A N=302 Adult Normative Performance of the Quotient ADHD System
ADHD
Primary: Well-screened, Non-ADHD Controls to Augment the Existing Adolescent and Adult Database Thus Expanding the Normative Reference Range of Performance of the Quotient®…
N/A N=53 Inhibitory Control Smartphone App
Drinking, Alcohol · Drinking Behavior
Primary: Number of Alcoholic Drinks Intended to Consume if They Were Free (i.e., Intensity) — 6.92; 7.33; 6.71 drinks — p=0.97
N/A N=228 Multi-site Anesthesia Randomized Controlled STudy of End Tidal Control Compared to Conventional Anesthesia Results
Et Control Performance in Adult Population Surgery
Primary: Percent Duration Without Large Deviation of End-Tidal Anesthetic Agent (EtAA) Based on Extraction Algorithm (ALG) — 91.7; 80.8 percent duration — p=<.001
N/A N=11 Hypoglycemia Prevention After Exercise in Adolescent T1DM Patients Using a Control to Range System
Type 1 Diabetes Mellitus
Primary: Hypoglycemic Events — 0.27; 1.0; 0.18; 0.18 events/patient
N/A N=368 Feasibility and Validation of a Standard Phenotyping Assessment Battery
Opioid-use Disorder · Cocaine Use Disorder · Marijuana Use Disorder
Primary: Retention — 4; 27; 10; 21 Participants
Early Phase 1 N=81 Testing Self-Control as a Behavior Change Mechanism to Increase Physical Activity
Sedentary Lifestyle · Self-control
Primary: Objective Physical Activity — 6184.45; 6671.81; 6647.71; 6932.25 Average Daily Steps — p=0.038
N/A N=17 Optimizing Closed-Loop Control of Type 1 Diabetes Mellitus in Adolescents
Diabetes Mellitus, Type 1
Primary: Percent of Time Spent Near Normoglycemia — 43.4; 18.9; 45.1; 21.3 percentage time near normoglycemia
N/A N=18 Evaluation of Hypo-Safe Hypoglycaemia Alarm Device - the Pilot 2 Study - Healthy Subjects
Healthy
Primary: Performance: EEG Recordings - Impedance — 2.3 Impedance (kOhm)
N/A N=200 Urinalysis Results in Healthy Individuals
Asymptomatic Bacteriuria · Asymptomatic Pyuria
Primary: False Positive Urine — 6; 40 Participants
N/A N=38 Sensor-controlled Digital Game for Heart Failure Self-management
Heart Failure
Primary: Number of Days With Weight-monitoring on Sensor Logs at 6 Weeks — 35.8; 32.9 days
N/A N=32 Diabetes Assistant (DiAs) Control-to-Range (CTR) Nocturnal Closed-Loop Camp Study
Diabetes Mellitus, Type 1
Primary: Percent Time Near Normoglycemia — 73; 52 percentage of time — p==0.037
N/A N=61 Healthy Weight for Teens
Obesity
Primary: Number of Participants With Successful Implemenmtation of BPE (Bundle of Program Enhancements) in Existing Multi-component PWM Programs — 20; 12 Participants
N/A N=58 Family Safety Net - Aim 3: Randomized Control Trial
Suicide · Accidental Injuries · Firearm Injury
Primary: Feasibility of the Intervention — 18; 40 Participants
N/A N=24 The Monitoring Study
Type1diabetes
Primary: Percentage of Time Spent With Dexcom CGMG < 60 mg/dl — 1.32; 1.95; 1.05; 0.99 percentage of time